2022
DOI: 10.1016/j.exer.2022.109197
|View full text |Cite
|
Sign up to set email alerts
|

Low expression of RBP4 in the vitreous humour of patients with proliferative diabetic retinopathy who underwent Conbercept intravitreal injection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 79 publications
0
1
0
Order By: Relevance
“…In this study, we linked RBP4 and tip cell formation, the vanguard of angiogenesis, to investigate the specific mechanism of RBP4 in neovascularization. Interestingly, it has been reported that RBP4 levels were elevated in the vitreous of patients with PDR disease and decreased after administration of anti-VEGF therapy, further demonstrating the potential value of RBP4 in RNV [ 61 ]. However, more complex mechanisms involving metabolism, immunity, neovascularization and fibrosis may remain to be elucidated given the unique pathologic state of diabetes.…”
Section: Discussionmentioning
confidence: 99%
“…In this study, we linked RBP4 and tip cell formation, the vanguard of angiogenesis, to investigate the specific mechanism of RBP4 in neovascularization. Interestingly, it has been reported that RBP4 levels were elevated in the vitreous of patients with PDR disease and decreased after administration of anti-VEGF therapy, further demonstrating the potential value of RBP4 in RNV [ 61 ]. However, more complex mechanisms involving metabolism, immunity, neovascularization and fibrosis may remain to be elucidated given the unique pathologic state of diabetes.…”
Section: Discussionmentioning
confidence: 99%